Related Experiment Video
Updated: Jul 10, 2026

Silencing of BRCA2 to Identify Novel BRCA2-regulated Biological Functions in Cultured Human Cells
Published on: August 12, 2015
Role played by BRCA1 in transcriptional regulation in response to therapy
M M Murray1, P B Mullan, D P Harkin
1Centre for Cancer Research and Cell Biology, Queen's University Belfast, 97 Lisburn Road, Belfast BT9 7AB, Northern Ireland, U.K.
Abstract:
BRCA1 (breast-cancer susceptibility gene 1) is a tumour suppressor, implicated in the hereditary predisposition to breast and ovarian cancer. BRCA1 has been implicated in a number of cellular processes including DNA repair and recombination, cell cycle checkpoint control, chromatin remodelling and ubiquitination. In addition, substantial data now exist to suggest a role for BRCA1 in transcriptional regulation; BRCA1 has been shown to interact with the Pol II holoenzyme complex and to interact with multiple transcription factors, such as p53 and c-Myc. We have previously identified a range of BRCA1 transcriptional targets and have linked these to specific cellular pathways, including cell cycle checkpoint activation and apoptosis. Current research is focused on the transcriptional mechanisms that underpin the association of BRCA1 deficiency with increased sensitivity to DNA damage-based chemotherapy and resistance to spindle poisons.
Insights
The breast-cancer susceptibility gene 1 (BRCA1) is crucial for DNA repair and cell cycle control. BRCA1 deficiency impacts chemotherapy sensitivity and resistance, highlighting its role in cancer development and treatment.
Area of Science:
- Genetics
- Molecular Biology
- Oncology
Background:
- BRCA1 is a tumor suppressor gene linked to hereditary breast and ovarian cancers.
- BRCA1 participates in DNA repair, cell cycle control, and chromatin remodeling.
- Emerging evidence suggests BRCA1's role in transcriptional regulation, interacting with transcription factors and the Pol II holoenzyme.
Purpose of the Study:
- To investigate the transcriptional mechanisms underlying BRCA1's function.
- To identify BRCA1 transcriptional targets and associated cellular pathways.
- To understand how BRCA1 deficiency affects chemotherapy sensitivity and resistance.
Main Methods:
- Identification of BRCA1 transcriptional targets.
- Analysis of cellular pathways linked to BRCA1 targets (e.g., cell cycle, apoptosis).
- Focus on transcriptional mechanisms related to chemotherapy sensitivity and resistance.
Main Results:
- Previously identified BRCA1 transcriptional targets and their pathway associations.
- Established links between BRCA1 targets and cell cycle checkpoint activation and apoptosis.
- Current research focuses on transcriptional mechanisms driving chemo-sensitivity and resistance.
Conclusions:
- BRCA1 plays a significant role in maintaining genomic stability and regulating cellular processes.
- Understanding BRCA1's transcriptional functions is key to explaining its tumor suppressor activity.
- BRCA1's role in transcriptional regulation is critical for developing targeted cancer therapies.
Related Concept Videos
Targeted Cancer Therapies
There are several types of targeted therapies against specific...
DNA Damage Can Stall the Cell Cycle
DNA Damage can Stall the Cell Cycle
Epigenetic Regulation
X-chromosome...
Epigenetic Regulation
Abnormal Proliferation

